Bavarian Nordic receives EMA approval of mpox vaccine for adolescents
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma
The wP-IPV-based hexavalent vaccination is an innovative immunization alternative to the current pentavalent and standalone IPV vaccines
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
Stressed was on the need to promote organ donation from the deceased persons to meet the huge need for organ donation in the country
Also received tentative approval for 137 mg
The partnership will provide health plans with an out-of-the-box compliance solution for CMS-9115 and CMS-0057 rules
Honeywell Quality Management Review helps manufacturers boost efficiency and quality compliance
Majority of organizations are looking to increase investments in public and hybrid cloud
Subscribe To Our Newsletter & Stay Updated